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The mutation rate of codon 43 was 57.5% (61/106). The
results of HRM of the 50 strains were identical to those of
sequencing.
Conclusion: Mutation in rpsL gene is the important
molecular mechanism of streptomycin resistance in
M.tuberculosis. High-resolution melting method is a
sensitive in-tube methodology to screen for mutations of
streptomycin resistance in M.tuberculosis. HRM analysis
using a dsDNA dye provides a useful tool and is applicable for
rapid and high-throughput screening of rpsL gene mutations
in M.tuberculosis.
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OL-010 Biochemical, immunological and virological
proﬁles of, and differential diagnosis between
patients with acute hepatitis B and chronic
hepatitis B with acute ﬂare
Y.N. Han, Q. Tang, W. Zhu, X.Q. Zhang, L.Y. You. Research
Unit of Liver Disease, Shanghai No. 8 People’s Hospital,
Shanghai 200235, China
Background and Aim: In areas of intermediate or high
prevalence of chronic hepatitis B virus (HBV) infection,
it is difﬁcult to distinguish acute hepatitis B (AHB) from
chronic hepatitis B with an acute ﬂare (CHB-AF) in patients
whose prior history of HBV infection was unknown. The
Immunoglobulin M antibody against hepatitis B core antigen
has been used as a differentiation indicator. The present
study aimed to screen other laboratory parameters to
construct a more efﬁcient joint diagnosis method.
Methods: A retrospective and prospective study was carried
out in patients ﬁrst clinically presenting as HBV-related
acute hepatitis to sort out the individuals with acute self-
limited hepatitis B (ASL-HB). Laboratory testing proﬁles
were compared between patients with ASL-HB and CHB-
AF. The sensitivity, speciﬁcity, accuracy, positive predictive
values, and negative predictive values for diagnosing AHB
of the parameters closely associated with ASL-HB were
evaluated.
Results: Signiﬁcant differences were observed between
patients with ASL-HB and CHB-AF in laboratory proﬁles,
and the differences showed in the increased levels of
serum HBVDNA, HBV e antigen (HBeAg), alpha-fetoprotein
(AFP) and anti-HBc IgM. Furthermore, It was found that
the population number of ASL-HB patients was signiﬁcantly
higher than that of CHB-AF in those with low levels positive
HBeAg (S/CO < 20) (42.7% vs 13.5%), but this was not found
in HBeAg negative group (49.3% vs 45.9%). For predicting
ASL-HB, the sensitivity and speciﬁcity of single 1:10 000
anti-HBc IgM were respectively 96.2% and 93.1%. Combining
anti-HBc IgM with HBVDNA, or and HBeAg could improve the
dignostic power. The combination of anti-HBc IgM, HBVDNA,
and HBeAg had a positive predictive value of 98.9% and a
negative predictive value of 100.0%, similar to those of the
combination of IgM anti-HBc and HBVDNA. AFP added to
either combination groups further increased the positive
predictive value. Both the positive predictive value and
negative predictive value of the combination of IgM anti-
HBc, HBVDNA and AFP were 100.0%.
Conclusions: (1) There are signiﬁcant differences in
biochemical, immunogical and virological aspects between
ASL-HB and CHB-AF. (2) Among several joint diagnostic
methods, IgM anti-HBc combining HBVDNA and AFP is the
most effective and practical in distinguishing ASL-HB from
CHB-AF. (3) A low HBeAg level is more helpful than negative
HBeAg in differential diagnosis between ASL-HB and CHB-AF.
(4) Patients with a high level of IgM anti-HBc, serum AFP
level >5×URL could rule out a probability of ASL-HB.
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Background and Aim: To study the impact of hepatitis B
e antigen on tumor recurrence and patients’ survival after
curative resection of hepatocellular carcinoma.
Methods: 203 patients with small hepatocellular carcinomas
(3 cm) undergone curative resection were divided
into HBeAg-positive group and HBeAg-negative group.
Clinicopathological factors and postoperative outcomes
were compared between groups, and risk factors for survival
and recurrence were studied.
Results: The median follow-up time is 32.9 months.
Those with negative HBeAg were better in both 5-year
overall survival (76% vs 53.9%, hazards ratio (HR): 2.363,
95%CI:1.335 4.181, P= 0.002) and 5-year disease-free
survival (52.9% vs 37.4%, HR: 1.603, 95%CI: 1.00 2.561,
P= 0.046).There was no signiﬁcant difference in operative
morbidity and tumor factors between the two groups,
but younger age, higher serum alanine aminotransferase
level, and more macronodular cirrhosis were found in
HBeAg-positive group. Multivariate analysis revealed that
age >50 years, HBeAg positivity and macronodular cirrhosis
were independent factors for overall survival, and HBeAg
positivity and multiple tumor nodules were independent
factors for disease-free survival. Positive serum HBeAg
associated with a higher risk of early recurrence (within
1 year).
Conclusions: Positive HBeAg associated with a higher risk
of early recurrence and poorer survival of patients after
curative resection of small HCC.
OL-012 HepG2.2.15 can induce the expression of PD-1
on T-cell: may be a mechanism of immune
tolerance in HBV infection
J. Chen*, X.J. Wu, Y.H. Wang, Y. Wang, J. Li, M. Yu,
N.L. Zhang, G.Q. Wang. Department of Infection Disease,
Peking University First Hospital, Beijing 10034, China
Background and Aims: To investigate the effect of
HepG2.2.15 a cell line transfected HBV geneome in
inducing PD-1 (Programmed cell death-1) expression on
T-cell, and the function of PD-1 on T-cell.
Methods: HepG2.2.15 were co-cultured with Jurkat cells,
which a kind of T lymphocyte. The PD-1 expression was
detected by ﬂow cytometry (FCM); Blocking test by adding
anti-PD-1 antibody in the experiment; Cytokines in culture
supernatant of blocking groups and control groups were
measured by enzyme-labeled immunosorbent assay (ELISA);
Cytotoxic test of T-cells in blocking groups and controls
were measured by methyl thiazolyl tetrazolium (MTT).
Results: The PD-1 expression on T-cells was induced
by HepG2.2.15, the expression rate is 17.43±5.6%
(control is 1.22±0.2%); The cytokines IL-2 level
(202.9±53.0 pg/ml), INF-g level (88.6±4.6 pg/ml) and IL-
10 level (63.7±13.4 pg/ml) in culture supernatant of
blocking groups were signiﬁcant higher than that of controls
(IL-2, 102.9±53 pg/ml, INF-g, 39.3±4.2 pg/ml and IL-10,
34.6±13.7 pg/ml, respectively. p < 0.05); The cytotoxic test
(OD value) was markedly higher in bloking group (0.29±0.06)
than that of control group (19±0.09, p < 0.05).
